Tilray will be reporting Q4 soon and looking at revenues for Canopy vs Tilray there's a huge difference! Canopy Q4 2023 had revenues of $72 Mil while Tilray is expected to report Q4 2024 revenues of $224 mil and Canopy FY 2023 was $297 mil almost what Tilray will make in one quarter. I have learned over a half-century that if the company has continued revenue increases can deal with any issues and Tilray FY 2024 will have close to $800 mil USD in revenues plus Tilray is really undervalued trading less than its Book value if it was to be bought by another company $2 SP wouldn't come close. Tilray is being punished because they're not fully integrated into the US market but that will change once the DEA reschedule marijuana and we all know that Tilray is a Healthcare company with expertise in Medical globally making a perfect fit for the rescheduling. Shorts are going to be eaten up before the bell rings very soon! and I do my homework!
Look at NR's from each company and Tilray is the winner that reads like a major in progress!!
U-CGC (stockwatch.com) U-TLRY (stockwatch.com) Tilray Q3 2024
Achieved Net Revenue of $188 Million, ~ 30% Net Revenue Growth Over the Prior Year Quarter
Beverage-Alcohol Net Revenue Increases 165% Over the Prior Year Quarter, 5th Largest Craft Beer Brewer in the U.S.1 with 4.5% Craft Beer Market Share
Global Cannabis Net Revenue Increases 33% with International Cannabis Growth of 44% Over the Prior Year Quarter, #1 Market Share in Canada and #1 Market Share in Germany
U.S. Cannabis Strategy in Place to Strike with Potential Drug Policy Reform